J. Safra Sarasin Holding Ag Apellis Pharmaceuticals, Inc. Transaction History
J. Safra Sarasin Holding Ag
- $5.91 Trillion
- Q4 2024
A detailed history of J. Safra Sarasin Holding Ag transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 60,347 shares of APLS stock, worth $1.62 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
60,347
Previous 73,577
17.98%
Holding current value
$1.62 Million
Previous $2.12 Billion
9.25%
% of portfolio
0.03%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding APLS
# of Institutions
302Shares Held
123MCall Options Held
2.63MPut Options Held
845K-
Avoro Capital Advisors LLC New York, NY12.2MShares$329 Million5.68% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$320 Million17.73% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$317 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$270 Million0.01% of portfolio
-
Morgan Stanley New York, NY9.63MShares$259 Million0.02% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.96B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...